Drug Trial Radar · NCT05099770
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
685
Planned (sponsor's estimate)
Start
Jan 5, 2022
Primary completion
Dec 2029
Study completion Dec 2029
Sponsor
- Lead sponsor
- ProkidneyIndustry
- Sponsor type
- Industry
- First posted
- Oct 29, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Conditions
- Type 2 Diabetes Mellitus
- Chronic Kidney Diseases
Interventions
Renal Autologous Cell Therapy (REACT/ rilparencel)Biological
Participants will have a kidney biopsy followed approximately12 weeks later with a rilparencel injection into the biopsied kidney, then, approximately 12 weeks later a rilparencel injection into their contralateral kidney.
Sham ComparatorProcedure
Participants will have sham procedures that simulate real biopsy and injection procedure. No tissue is taken during biopsy and nothing is injected into kidney. The 2 injection/ sham procedures will occur approximately 12 weeks apart.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surrogate / Intermediate Efficacy Endpoint -eGFR SlopeTime frame: 18 months after the 135th participant receives their first injection / sham.
- Clinical EndpointTime frame: From date of first injection until the date of first event: 40% reduction in eGFR, eGFR < 15 mL/min/1.73m² and/or chronic dialysis, and or renal transplant or date of renal or cardiovascular death, whichever came first, assessed up to 94 months.
Locations
88 sites in 4 countries. Site status is shown where the registry gives one.
Nephrology Consultants
Huntsville, Alabama
University of Arizona
Tucson, Arizona
Amicis Research Center
Beverly Hills, California
Kidney Consultants Medical Group
Granada Hills, California
IMD Clinical Trials
Huntington Park, California
Advanced Medical Research, LLC
Lakewood, California
Medicine and Nephrology Associates
Los Alamitos, California
Academic Medical Research Institute
Los Angeles, California
Southern California Hospital
Los Angeles, California
Allameh Medical Corporation
Mission Viejo, California
Golden Pacific Nephrology Medical Clinic Inc
Monterey Park, California
Northridge Kidney Care Center
Northridge, California
Valley Renal Medical Group
Northridge, California
Valley Clinical Trials
Northridge, California
Integrity Medical Discovery
Pico Rivera, California
National Institute of Clinical Research
Pomona, California
Nephrology Associates Medical Group
Riverside, California
UC Davis Medical Group GI Unit
Sacramento, California
North America Research Institute
San Dimas, California
Henry Mayo Newhall Hospital
Valencia, California
Nephrology Associates PA
Newark, Delaware
West Broward Research Institute
Coral Springs, Florida
Florida Kidney Physicians
Fort Lauderdale, Florida
South Fort Lauderdale Nephrology
Fort Lauderdale, Florida
University of Florida
Gainesville, Florida
Mayo Clinic
Jacksonville, Florida
Ethos Palm Beach
Loxahatchee Groves, Florida
Global Clinix, LLC
Miami, Florida
Professional Research Center, Inc.
Miami, Florida
New Phase Clinical Trials
Miami Beach, Florida
Infigo Clinical Research
Sanford, Florida
Genesis Clinical Research
Tampa, Florida
American Clinical Trials
Acworth, Georgia
Wellstar Health System
Augusta, Georgia
Boise Kidney and Hypertension PLLC
Boise, Idaho
Care Institute
Chubbuck, Idaho
Insight Hospital & Medical Center Chicago
Chicago, Illinois
The University of Chicago Medical Center
Chicago, Illinois
Indiana Nephrology
Fishers, Indiana
Fresenius Kidney Care Mishawaka
Mishawaka, Indiana
Showing 40 of 88 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.